OXIDATIVE STRESS AND ANTHEROSCLEROTIC COMPLICATIONS OF DIABETES
OXIDATIVE STRESS AND ANTHEROSCLEROTIC COMPLICATIONS OF DIABETES
批准号:
6244436
负责人:
FRANCESCA CATELLA-LAWSON
金额:
$2.36万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-17 至 1998-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The role of the oxidant stress in the evolution of diabetic vascular
complications is unclear. This reflects, in part, limitation of current
methodology to access free radical generation in vivo. The isopstanes are
a family of prostaglandin isomers formed in a free radical catalyzed
manner from arachidonic acid, initially esterfied in the phospholipid from
which they are cleaved by phospholipases. A quantitative method for an F2
isoprostane, 8-epi-PGF2alpha, using gas chromatography / mass spectometry
(GC/MS), will be utilized to address the hypothesis that oxidative stress
is enhanced in diabetes and that this precededes the onset of micro or
macrovascular disease. Urinary 8-epi-PGF2alpha and the diene conjugate
ratio, will be measured in diabetics with and without retinopathy, with
and without macrovascular disease and in appropriate controls. To address
the hypothesis that oxidation of LDL in diabetes might be facilitated by
accumulation of advanced glycosylation end products (AGEs), we will
isolate LDL to access esterfied 8-epi-PGF2alpha and both apo-B- and lipid-
linked AGEs. Additionally, in these subjects we will access the formation
of esterfied isoprostanes in the LDL oxidized in vitro in response to
copper. Finally, we will address the hypothesis that chronic
administration of the antioxidants, vitamins E & C, will depress urinary
8-epi-PGF2alpha concomitantly with modulation of LDL susceptability to
oxidation.
These studies will provide the first information using a novel
quantitative approach, on free radical generation in vivo in human
diabetes. They will address the hypothesis that increased oxidative
stress preceeds the onset of clinically detectable vascular complications
and that it is reflected both systematically and in LDL by isoprostane
formation. Preliminary information will be obtained on the potenial role
of vitamin E and C antioxidant drugs in diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
METABOLISM OF 8 EPI PGF2 IN HEALTHY VOLUNTEERS
-
批准号:6565822
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2001
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
OXIDATIVE STRESS AND ATHEROSCLEROTIC COMPLICATIONS OF DIABETES
-
批准号:6565903
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2001
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
PHARMACODYNAMIC INTERACTION: GPIIB/IIIA ANTAGONIST/ASPIR
-
批准号:6565814
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2001
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
SELECTIVE INHIBITION OF CYCLOOXYGENASE-2 IN ATHEROSCLEROSIS
-
批准号:6565791
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2001
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
METABOLISM OF 8 EPI PGF2 IN HEALTHY VOLUNTEERS
-
批准号:6468072
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2000
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
SELECTIVE INHIBITION OF CYCLOOXYGENASE-2 IN ATHEROSCLEROSIS
-
批准号:6468041
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2000
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
OXIDATIVE STRESS AND ATHEROSCLEROTIC COMPLICATIONS OF DIABETES
-
批准号:6468153
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2000
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
PHARMACODYNAMIC INTERACTION: GPIIB/IIIA ANTAGONIST/ASPIR
-
批准号:6468064
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2000
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
METABOLISM OF 8 EPI PGF2 IN HEALTHY VOLUNTEERS
-
批准号:6303299
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1999
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
OXIDATIVE STRESS AND ATHEROSCLEROTIC COMPLICATIONS OF DIABETES
-
批准号:6303355
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1999
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
OXIDATIVE STRESS AND ATHEROSCLEROTIC COMPLICATIONS OF DIABETES
-
批准号:6113233
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1998
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
METABOLISM OF 8 EPI PGF2 IN HEALTHY VOLUNTEERS
-
批准号:6263596
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1998
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
PHARMACODYNAMICS, & PLASMA CONCENTRATION PROFILE OF L 734,217
-
批准号:6263608
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1998
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
RPR 109891 ORALLY FOR 8 WEEKS IN PTS WITH RECENT ACUTE CORONARY ARTERY SYNDROMES
-
批准号:6274532
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
OXIDATIVE STRESS AND ATHEROSCLEROTIC COMPLICATIONS OF DIABETES
-
批准号:6274467
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
RPR 109891 ORALLY FOR 8 WEEKS IN PTS WITH RECENT ACUTE CORONARY ARTERY SYNDROMES
-
批准号:6113298
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1998
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
OXIDATIVE STRESS AND ANTHEROSCLEROTIC COMPLICATIONS OF DIABETES
-
批准号:5216087
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:--
RPR 109891 ORALLY FOR 8 WEEKS IN PTS WITH RECENT ACUTE CORONARY ARTERY SYNDROMES
-
批准号:6327860
-
项目类别:
-
资助金额:$18.75万
-
财政年份:--
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
RPR 109891 ORALLY FOR 8 WEEKS IN PTS WITH RECENT ACUTE CORONARY ARTERY SYNDROMES
-
批准号:6335233
-
项目类别:
-
资助金额:$18.75万
-
财政年份:--
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
RPR 109891 ORALLY FOR 8 WEEKS IN PTS WITH RECENT ACUTE CORONARY ARTERY SYNDROMES
-
批准号:6303413
-
项目类别:
-
资助金额:$2.51万
-
财政年份:--
-
负责人:FRANCESCA CATELLA-LAWSON
-
依托单位:
海外基金